Mobile health – technology and outcomes in low- and middle-income countries (R21/R33 clinical trial optional)

Summary text: This supports the study of the development, validation feasibility and effectiveness of innovative mobile health interventions or tools specifically suited for low- and middle-income countries. Grants are worth up to USD 850,000 each over up to five years.